 |
 |
 |
 |
 |
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||||||||||||||||||
|
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
|
MetaMorphix®'s internal focus is on near-term agricultural opportunities and establishing pharmaceutical partnerships for human therapeutic opportunities. MetaMorphix® expects its main platform technologies; growth factors and livestock genomics to transform the $1 trillion livestock production industry. Myostatin, the Company's lead growth factor and regulator of skeletal muscle, is arguably the most important gene discovery in the history of livestock production. MetaMorphix® also expects to receive substantial milestone and royalty payments from the pharmaceutical development of Myostatin for treatment of human muscular degenerative diseases, as well as Type II diabetes and obesity. MetaMorphix® has made strategic business and research alliances and acquisitions enhancing product and business opportunities. MetaMorphix® has exclusive access to Celera's livestock genomics assets including completed sequences and SNP maps for chicken, swine and cattle. The Company has also acquired Celera's AgGen subsidiary, the largest animal genotyping facility in the world. Livestock genomic assets are being used to develop selection tools that will create new breeds, select superior animals during production and certify meat. Committed R&D partnerships with leading companies and research institutions including The Johns Hopkins University, Wyeth, USDA and Celera Genomics. MetaMorphix® has a strong patent position and research and MetaMorphix® team of dedicated scientists and professionals is developing tools and technologies designed to enable producers and processors to reduce production costs, improve animal health, enhance meat yield and quality, improve safety and nutritional value, enhance uniformity and product differentiation and reduce environmental impact. Strong IP position and additional product development opportunities in 47 issued and 41 pending patents. MetaMorphix® has created the right environment for success of its business and its people. MetaMorphix® has an experienced, well-respected Management Group and Board, with deep backgrounds in the livestock and agriculture business. |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
 |
||||||||||||||||||
